Literature DB >> 21282190

Prevention of hepatitis C virus in injecting drug users: a narrow window of opportunity.

Jason Grebely, Gregory J Dore.   

Abstract

Entities:  

Mesh：

Year:  2011        PMID： 21282190      PMCID： PMC3072734          DOI： 10.1093/infdis/jiq111

Source DB:  PubMed          Journal:  J Infect Dis        ISSN： 0022-1899            Impact factor:   5.226


× No keyword cloud information.
  40 in total

1.  Hepatitis C in hospital employees with needlestick injuries.

Authors:  K Kiyosawa; T Sodeyama; E Tanaka; Y Nakano; S Furuta; K Nishioka; R H Purcell; H J Alter
Journal:  Ann Intern Med       Date:  1991-09-01       Impact factor: 25.391

2.  Incidence of hepatitis C virus infection among injection drug users during an outbreak of HIV infection.

Authors:  D M Patrick; M W Tyndall; P G Cornelisse; K Li; C H Sherlock; M L Rekart; S A Strathdee; S L Currie; M T Schechter; M V O'Shaughnessy
Journal:  CMAJ       Date:  2001-10-02       Impact factor: 8.262

3.  Can Hepatitis C virus treatment be used as a prevention strategy? Additional model projections for Australia and elsewhere.

Authors:  Peter Vickerman; Natasha Martin; Matthew Hickman
Journal:  Drug Alcohol Depend       Date:  2010-09-15       Impact factor: 4.492

Review 4.  Candidate hepatitis C vaccine trials and people who inject drugs: challenges and opportunities.

Authors:  Lisa Maher; Bethany White; Margaret Hellard; Annie Madden; Maria Prins; Thomas Kerr; Kimberly Page
Journal:  Vaccine       Date:  2010-09-09       Impact factor: 3.641

5.  Major decline of hepatitis C virus incidence rate over two decades in a cohort of drug users.

Authors:  Charlotte H S B van den Berg; Colette Smit; Margreet Bakker; Ronald B Geskus; Ben Berkhout; Suzanne Jurriaans; Roel A Coutinho; Katja C Wolthers; Maria Prins
Journal:  Eur J Epidemiol       Date:  2007-03-03       Impact factor: 8.082

6.  Limited uptake of hepatitis C treatment among injection drug users.

Authors:  Shruti H Mehta; Becky L Genberg; Jacquie Astemborski; Ravi Kavasery; Gregory D Kirk; David Vlahov; Steffanie A Strathdee; David L Thomas
Journal:  J Community Health       Date:  2008-06

7.  Modelling the hepatitis C virus epidemic in Australia.

Authors:  Karina Razali; Hla Hla Thein; Jane Bell; Mark Cooper-Stanbury; Kate Dolan; Greg Dore; Jacob George; John Kaldor; Maria Karvelas; Jiong Li; Lisa Maher; Sharyn McGregor; Margaret Hellard; Fiona Poeder; Julianne Quaine; Kim Stewart; Helen Tyrrell; Martin Weltman; Owen Westcott; Alex Wodak; Matthew Law
Journal:  Drug Alcohol Depend       Date:  2007-07-31       Impact factor: 4.492

8.  Hepatitis C virus incidence among young street-involved IDUs in relation to injection experience.

Authors:  Elise Roy; Jean-François Boudreau; Jean-François Boivin
Journal:  Drug Alcohol Depend       Date:  2009-02-28       Impact factor: 4.492

9.  Unstable housing and hepatitis C incidence among injection drug users in a Canadian setting.

Authors:  Christina Kim; Thomas Kerr; Kathy Li; Ruth Zhang; Mark W Tyndall; Julio S G Montaner; Evan Wood
Journal:  BMC Public Health       Date:  2009-07-29       Impact factor: 3.295

10.  Elevated rates of HIV infection among young Aboriginal injection drug users in a Canadian setting.

Authors:  Cari L Miller; Steffanie A Strathdee; Patricia M Spittal; Thomas Kerr; Kathy Li; Martin T Schechter; Evan Wood
Journal:  Harm Reduct J       Date:  2006-03-08
View more
  12 in total

1.  Agent-based and phylogenetic analyses reveal how HIV-1 moves between risk groups: injecting drug users sustain the heterosexual epidemic in Latvia.

Authors:  Frederik Graw; Thomas Leitner; Ruy M Ribeiro
Journal:  Epidemics       Date:  2012-05-02       Impact factor: 4.396

2.  The opioid epidemic and injection drug use: MIPIE and health harms related to the injection of prescription opioids.

Authors:  Pedro Mateu-Gelabert; Honoria Guarino
Journal:  Int J Drug Policy       Date:  2018-04-05

3.  Opioid Use Trajectories, Injection Drug Use, and Hepatitis C Virus Risk Among Young Adult Immigrants from the Former Soviet Union Living in New York City.

Authors:  Honoria Guarino; Lisa A Marsch; Sherry Deren; Shulamith L A Straussner; Anastasia Teper
Journal:  J Addict Dis       Date:  2015

4.  Using qualitative data, people's perceptions, and the science of decision making to inform policy and improve hepatitis C care for people who use drugs.

Authors:  David C Perlman; Ashly E Jordan
Journal:  Int J Drug Policy       Date:  2014-10-31

5.  Initiating HCV treatment with direct acting agents in opioid agonist treatment: When to start for people co-infected with HIV?

Authors:  Dimitra Panagiotoglou; Emanuel Krebs; Jeong Eun Min; Michelle Olding; Keith Ahamad; Lianping Ti; Julio S G Montaner; Bohdan Nosyk
Journal:  Int J Drug Policy       Date:  2017-06-01

6.  Cohort profile: the international collaboration of incident HIV and hepatitis C in injecting cohorts (InC3) study.

Authors:  Jason Grebely; Meghan D Morris; Thomas M Rice; Julie Bruneau; Andrea L Cox; Arthur Y Kim; Barbara H McGovern; Naglaa H Shoukry; Georg Lauer; Lisa Maher; Andrew R Lloyd; Margaret Hellard; Maria Prins; Gregory J Dore; Kimberly Page
Journal:  Int J Epidemiol       Date:  2012-11-30       Impact factor: 7.196

7.  Resilience among IDUs: planning strategies to help injection drug users to protect themselves and others from HIV/HCV infections.

Authors:  Skultip Sirikantraporn; Pedro Mateu-Gelabert; Samuel R Friedman; Milagros Sandoval; Rafael A Torruella
Journal:  Subst Use Misuse       Date:  2012-05-10       Impact factor: 2.164

8.  Phylogenetic clustering of hepatitis C virus among people who inject drugs in Vancouver, Canada.

Authors:  A F Poon; J Grebely; B Jacka; T Applegate; M Krajden; A Olmstead; P R Harrigan; Bdl Marshall; K DeBeck; M-J Milloy; F Lamoury; O G Pybus; V D Lima; G Magiorkinis; V Montoya; J Montaner; J Joy; C Woods; S Dobrer; G J Dore
Journal:  Hepatology       Date:  2014-09-29       Impact factor: 17.425

9.  High burden of hepatitis C & HIV co-infection among people who inject drugs in Manipur, Northeast India.

Authors:  Michelle Kermode; Amenla Nuken; Gajendra Kumar Medhi; Brogen Singh Akoijam; H Umesh Sharma; Jagadish Mahanta
Journal:  Indian J Med Res       Date:  2016-03       Impact factor: 2.375

10.  Declining incidence of hepatitis C virus infection among people who inject drugs in a Canadian setting, 1996-2012.

Authors:  Jason Grebely; Viviane Dias Lima; Brandon D L Marshall; M-J Milloy; Kora DeBeck; Julio Montaner; Annick Simo; Mel Krajden; Gregory J Dore; Thomas Kerr; Evan Wood
Journal:  PLoS One       Date:  2014-06-04       Impact factor: 3.240
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.